Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma
about
Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacyComment on 'Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'.Reply to: Comment on 'Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'.Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2
P2860
Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combined cancer testis antigen ...... with hepatocellular carcinoma
@ast
Combined cancer testis antigen ...... with hepatocellular carcinoma
@en
type
label
Combined cancer testis antigen ...... with hepatocellular carcinoma
@ast
Combined cancer testis antigen ...... with hepatocellular carcinoma
@en
prefLabel
Combined cancer testis antigen ...... with hepatocellular carcinoma
@ast
Combined cancer testis antigen ...... with hepatocellular carcinoma
@en
P2093
P2860
P1476
Combined cancer testis antigen ...... with hepatocellular carcinoma
@en
P2093
Dongli Yue
Jiansheng Li
Liping Wang
Longshuan Zhao
Tengfei Zhang
P2860
P304
P577
2015-04-01T00:00:00Z